Search Results - "Borghini, U"

A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer by Soresi, E, Clerici, M, Grilli, R, Borghini, U, Zucali, R, Leoni, M, Botturi, M, Vergari, C, Luporini, G, Scoccia, S

“…Cis-Dichlorodiammine platinum (II) (cis-DDP) was demonstrated to be a potentiator of radiation therapy (RT) in experimental tumor models and in cultured cells…”
Get more information

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non–Small-Cell Lung Cancer by Scagliotti, Giorgio V., Fossati, Roldano, Torri, Valter, Crinò, Lucio, Giaccone, Giuseppe, Silvano, Giovanni, Martelli, Massimo, Clerici, Maurizia, Cognetti, Francesco, Tonato, Maurizio

“…Background: Surgery is the primary treatment for patients with stage I, II, or IIIA non–small-cell lung cancer (NSCLC). However, long-term survival of NSCLC…”
Get full text

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP) by Baldini, E, Tibaldi, C, Ardizzoni, A, Salvati, F, Antilli, A, Portalone, L, Barbera, S, Romano, F, De Marinis, F, Migliorino, M R, Noseda, M A, Borghini, U, Crippa, M, Ferrara, G, Raimondi, M, Fioretti, M, Bandera, M, Pennucci, M C, Galeasso, G, Cacciani, G C, Lepidini, G, Sunseri, G, Lanfranco, C, Rinaldi, M, Rosso, R

“…In the present multicentre randomized phase II trial, the activity and toxicity of three platinum-based combination regimens for the treatment of advanced…”
Get full text

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study by Ardizzoni, A, Addamo, GF, Baldini, E, Borghini, U, Portalone, L, De Marinis, F, Lionetto, R, Conte, PF, Bruzzi, P, Pennucci, MC

Get full text

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force by Ardizzoni, A, Addamo, G F, Baldini, E, Borghini, U, Portalone, L, De Marinis, F, Lionetto, R, Conte, P F, Bruzzi, P, Pennucci, M C

“…The FONICAP group is screening, with randomised phase II studies, the activity of new chemotherapy programmes for advanced non-small-cell lung cancer (NSCLC)…”
Get full text

Effect of octreotide on neuroenolase levels in patients with small cell lung cancer by Soresi, E, Invernizzi, G, Boffi, R, Borghini, U, Schiraldi, G, Mantellini, P V, Gramegna, G, Liuzzi, A

“…The somatostatin analog octreotide has an antiproliferative effect on small cell lung cancer lines in vitro and in experimental xenograft transplantation…”
Get more information

Massive haemoptysis in Behçet syndrome: case report by Barberis, M, Casadio, C, Borghini, U

“…Behçet syndrome in association with pulmonary manifestations is rare. We describe a patient suffering from recurrent oral and genital ulcerations,…”
Get more information

Cis-platin and radiotherapy in the treatment of unresectable lung cancer by Soresi, E, Borghini, U, Harari, S, Scoccia, S, Torre, M, Botturi, M, Leoni, M

“…The goal of this pilot study was to verify the efficacy of the association of cisplatin plus radiotherapy in the treatment of lung cancer. Thirty-seven…”
Get more information

Radiotherapy versus radiotherapy plus cisplatin treatment for locally advanced non small cell lung cancer: preliminary results of a randomized study by Clerici, M, Soresi, E, Zucali, R, Borghini, U, Vergani, C, Leoni, M, Botturi, F, Luporini, G

“…Preliminary results of a randomized study (radiotherapy versus radiotherapy plus weekly low-dose cisplatin) are reported. Fifty-four patients (43 evaluable)…”
Get more information

Carcinoid tumors of the lung. Report of 66 cases by Barberis, M, Valagussa, E, Pieri Nerli, F, Torre, M, Borghini, U

Get more information

Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer by Spinazzi, A, Soresi, E, Borghini, U, Boffi, R, Vigorelli, R, Scoccia, S

Get more information

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study by BALDINI, E, TIBALDI, C, NOSEDA, M. A, BORGHINI, U, CRIPPA, M, FERRARA, G, RAIMONDI, M, FIORETTI, M, BANDERA, M, PENNUCCI, M. C, GALEASSO, G, CACCIANI, G. C, ARDIZZONI, A, LEPIDINI, G, SUNSERI, G, LANFRANCO, C, RINALDI, M, LIONETTO, R, CONTE, P. F, ROSSO, R, SALVATI, F, ANTILLI, A, PORTALONE, L, BARBERA, S, ROMANO, F, DE MARINIS, F, MIGLIORINO, M. R

Get full text

679 Anti calretinin anti serum: A new tool in the cytological evaluation of serous effusions by Barberis, M.C.P., Borghini, U., Veronese, S., Faleri, M., Casadio, C., Viale, G.

Get full text

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-lung cancer : a FONICAP randomised phase II study by ARDIZZONI, A, ADDAMO, G. F, VENTURINI, M, RINALDI, M, ROSSO, R, SALVATI, F, BALDINI, E, BORGHINI, U, PORTALONE, L, DE MARINIS, F, LIONETTO, R, CONTE, P. F, BRUZZI, P, PENNUCCI, M. C

Get full text

Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer by Soresi, V, Invernizzi, G, Schiraldi, G, Borghini, U, Sacerdoti, Jr, C, Maruzzi, M

Get more information